Raynich, Y. S., Skaterna, T. D., Gerashenko, D. S., Hudkova, O. O., Kishko, T. O., & Latyshko, N. V. (2023). Increased expression level of adaptor protein Cuk/CIN85 in doxorubicin-resistant human non-small lung adenocarcinoma MOR cells is associated with their metabolic reprogramming.
Чикаго стиль цитування (17-те видання)Raynich, Y. S., T. D. Skaterna, D. S. Gerashenko, O. O. Hudkova, T. O. Kishko, та N. V. Latyshko. Increased Expression Level of Adaptor Protein Cuk/CIN85 in Doxorubicin-resistant Human Non-small Lung Adenocarcinoma MOR Cells Is Associated with Their Metabolic Reprogramming. 2023.
Стиль цитування MLA (8-ме видання)Raynich, Y. S., et al. Increased Expression Level of Adaptor Protein Cuk/CIN85 in Doxorubicin-resistant Human Non-small Lung Adenocarcinoma MOR Cells Is Associated with Their Metabolic Reprogramming. 2023.